Informations générales (source: ClinicalTrials.gov)
Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia
Observational
Assistance Publique - Hôpitaux de Paris (Voir sur ClinicalTrials)
mars 2023
mars 2031
16 décembre 2025
The purpose of this study is to assess medical events during follow-up of adult patients
having hypophosphatasia and consulting rheumatologists.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| AP-HP Assistance publique - Hôpitaux de Paris | 13/12/2025 07:36:42 | Contacter | |||
| AP-HP - Hôpital Cochin | |||||
| AP-HP - Hôpital Lariboisiere-Fernand Widal | |||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| CHU de Toulouse - 31059 - Toulouse - France | Guillaume COUTURE, MD | Contact (sur clinicalTrials) | |||
| CHU Lille - 59000 - Lille - France | Bernard Cortet, MD | Contact (sur clinicalTrials) | |||
| CHU Nice - Nice - France | Véronique BREUIL | Contact (sur clinicalTrials) | |||
| CHU Poitiers - 86000 - Poitiers - France | Guillaume LARID, MD | Contact (sur clinicalTrials) | |||
| CHU Rennes - 35000 - Rennes - France | Pascal GUGGENBUHL | Contact (sur clinicalTrials) | |||
| CHU Saint-Etienne - 42270 - Saint-Priest-en-Jarez - France | Thierry THOMAS, MD | Contact (sur clinicalTrials) | |||
| Hospices Civils de Lyon - 69003 - Lyon - France | emmanuelle VIGNOT, MD | Contact (sur clinicalTrials) | |||
| Lariboisière Hospital - 75010 - Paris - France | Hang Korng EA, MD | Contact (sur clinicalTrials) | |||
| Les hôpitaux universitaires de Strasbourg - 67200 - Strasbourg - France | Rose-Marie JAVIER, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- men and women,
- aged 18 and over, with no upper age limit, who have had a total alkaline phosphatase
value of less than 40 IU/l on at least 3 occasions,
- with at least one rheumatological symptom.
- men and women,
- aged 18 and over, with no upper age limit, who have had a total alkaline phosphatase
value of less than 40 IU/l on at least 3 occasions,
- with at least one rheumatological symptom.
- transient hypophosphatasia: absence of confirmation of a value below 40 IU/l on at
least 3 samples,
- secondary hypophosphatasia according to the expert rheumatologist (drugs, endocrine
disease, other genetic disease...).